We are a leading Australian #medicalcannabis#research centre within the @BrainMind_Usyd @Sydney_Uni investigating the therapeutic potential of cannabis 🌱
Researchers at @InsideOutInst and @Lambert_Usyd are seeking volunteers with Anorexia Nervosa to take part in a study investigating a new plant-based treatment.
Find out more at https://t.co/Ud6V6cDeSy
Promising results from the @Lambert_Usyd 4 week trial of topical CBD in hand osteoarthritis, in conjunction with @AvechoLtd and @NTFGroup. Pain, stiffness and anxiety reduced, grip strength increased. Great work from Zeeta Bawa et al #CBD#arthritis https://t.co/1uvaALmFTS
Exercise beats drugs! New study from @Lambert_Usyd led by @DuckyMcCartney with @irwin_cg and Griffith Uni pals. CBD (150 mg) no effect on enjoyment or pain during or after a 10 km run. Running itself is a great anxiolytic & mood enhancer. #CBD#exercise https://t.co/hkrQApMHY6
Did you know long-term oral THC exposure increased the lifespan of rats in a preclinical “toxicology” study”? This and other fun facts in our new review on cannabinoids and ageing. @Lambert_Usyd https://t.co/mwy7OK0liR
🗣️ "Roadside drug tests have limitations, the field sobriety tests also have limitations. What we're hoping to work towards is a better behavioural test using more tech [and] things like computerised cognitive tasks."
🙌 @DuckyMcCartney for @SBSNews ⤵️
https://t.co/nrIMoORXmO
New paper by @OliviaMDobson w @MikeySavic & @MyfGraham has found a range of complex factors affecting practitioners’ approaches to prescribing medical cannabis.
Read the paper, w policy & practice recs: https://t.co/W2lrnzYKUZ
Article in RACGP News:
https://t.co/wPmwXWaS7w
🎙️What can the UK #medicalcannabis industry learn from Australia?
@iainsmcgregor joins industry leaders in an impactful panel discussion about the successes and mistakes of the current Australian medical cannabis industry.
Listen now 👇
https://t.co/tSoe3Td3mQ
🎉 Professor Iain McGregor has been awarded the @IACM_Bulletin Award for Clinical Research!
He will be speaking at their upcoming conference on the 12 & 13 of April. The event is online, with free registration: https://t.co/emqKN7zuUX
We look forward to seeing you online!
🧪 Congratulations to recent PhD graduate @eric_sparkes for his two recent publications synthesising SCRAs and investigating their functionality at cannabinoid receptors. We can't wait to see what you do next! 🥂
Latest work from @Lambert_Usyd is online in @ACSChemNeurosci!
In another great collaboration with @christophestove et al., we looked at the recently detected synthetic cannabinoid ADB-HEXINACA and related analogues as emerging NPS🧪🔍
https://t.co/Sra7FCUERl
More SCRA work from @Lambert_Usyd out now in @rsc_medchem!
We looked at a series of proteinogenic amino acid-derived SCRAs related to MPP-5F-PICA, MMB-5F-PICA, and MDMB-5F-PICA, investigating the role of chirality in CB1 and CB2 receptor activation.
https://t.co/IpUb6vpCRH
Excited to hear our PhD Candidate @sarah_rodan speak at @aedrtc about her new clinical trials with #cannabidiol and #psychedelics! Register for this exciting talk by clicking on the link 👉 https://t.co/vzhc5pSb2b
Tune in at lunch time on 13th March with @sarah_rodan and Claire Finkelsteinas they showcase their research about cannabidiol and psychedelics for the treatment of eating disorders.
➡️ Register https://t.co/0dHJJfKbdz
📢 New research published!
We tested the sensitivity of point-of collection testing devices that are often used in RDTs and workplaces!
Click through to learn more:
🔗 https://t.co/53rFeObfxg
🙌 @AnastasiaSuraev @DuckyMcCartney@RichardKevinPhD@HoyosCamilla@iainsmcgregor
We're pleased to see the latest National Drug Strategy Household Survey 2022-23 results, released today by @aihw
Report findings reveal increased public support for sensible health-centred drug policy reform, such as regulating cannabis.
Read more: https://t.co/lHxqeOOICR
CALL FOR ABSTRACTS – EXTENDED to MARCH 1 - Join us for #ICRS2024SALAMANCA! Our 34th Annual ICRS Symposium on the Cannabinoids – June 30-July 5, 2024 #cannabis#cannabinoid#science https://t.co/9jMHXH1QWN https://t.co/OCXxQAurIv
New paper alert ⤵️
https://t.co/UjlEWWWVDX
🔑 A sub-analysis of the Cannabis as Medicine Survey 2020 showed prescribing of #medicinalcannabis does not always align with clinical practice
🎓 Educating prescribers will prevent avoidable side effects and improve patient support
📩'The “Next Day” Effects of Cannabis Use: A Systematic Review' was one of the top downloaded papers in @CannabisJrnl for 2023!
🙌Congrats to @DuckyMcCartney @AnastasiaSuraev @iainsmcgregor
Read it here 👉 https://t.co/qMCqiXS1G4
This week, we will be providing a roundup of the highlights from 2023 in Cannabis and Cannabinoid Research. Let's dive into the key developments and advancements that took place in the past year. 🥂 🗓️ 🌿
1️⃣ First, let's review the ten most frequently accessed articles in 2023:
Our latest report Cannabis in Australia 2023 found the number of approvals for prescribed #medicinalcannabis in Australia has continued to grow this year, despite barriers to access. A thread 🧵
Follow this link to download Cannabis in Australia 2023: https://t.co/EmbIkdPGAm